.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Fish and Richardson
Federal Trade Commission
McKesson
Novartis
Chubb
Cantor Fitzgerald
US Army
Argus Health

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206679

« Back to Dashboard

NDA 206679 describes FLOLIPID, which is a drug marketed by Tcg Fluent Pharma and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the FLOLIPID profile page.

The generic ingredient in FLOLIPID is simvastatin. There are thirty-nine drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the simvastatin profile page.

Summary for 206679

Tradename:1
Applicant:1
Ingredient:1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 206679

Suppliers and Packaging for NDA: 206679

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLOLIPID simvastatin SUSPENSION;ORAL 206679 NDA Salerno Pharmaceuticals Co. 29273-401 29273-401-04 150 mL in 1 BOTTLE, GLASS (29273-401-04)
FLOLIPID simvastatin SUSPENSION;ORAL 206679 NDA Salerno Pharmaceuticals Co. 29273-402 29273-402-04 150 mL in 1 BOTTLE, GLASS (29273-402-04)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength20MG/5ML
Approval Date:Apr 21, 2016TE:RLD:Yes
Patent:► SubscribePatent Expiration:Feb 23, 2030Product Flag?YSubstance Flag?Delist Request?

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrength40MG/5ML
Approval Date:Apr 21, 2016TE:RLD:Yes
Patent:► SubscribePatent Expiration:Feb 23, 2030Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Federal Trade Commission
Mallinckrodt
Chinese Patent Office
Covington
Boehringer Ingelheim
Chubb
Harvard Business School
Colorcon
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot